Atara Biotherapeutics, Inc.

ATRA · Healthcare

$9.76

Capitalización: 97.97M USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Atara Biotherapeutics, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Business Wire12 ago 2026, 20:05

Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress

Associated Press12 ago 2026, 20:10

Atara Biotherapeutics: Q2 Earnings Snapshot

Business Wire12 jun 2026, 20:00

Atara Biotherapeutics Announces Changes to Its Board of Directors

GlobeNewswire11 jun 2026, 10:52

Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia